ADMA EPS Estimates
ADMA Biologics, Inc.
$11.07
+$0.39(+3.65%)
72
Overall
70
Value
83
Tech
65
Quality
Market Cap
$2.39B
Volume
2.87M
52W Range
$7.21 - $20.46
Target Price
$15.80
ADMA EPS estimates: the consensus estimate for ADMA Biologics, Inc.'s current fiscal year is $0.78 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ADMA EPS Estimates
- EPS estimate, current quarter
- $0.19
- EPS estimate, next quarter
- $0.22
- EPS estimate, current year
- $0.78
- EPS estimate, next year
- $0.85
- EPS growth, 3-year
- +57.12%
| Fiscal year | EPS |
|---|---|
| 2025 | $0.62 |
| 2024 | $0.85 |
| 2023 | $-0.13 |
| 2022 | $-0.33 |
| 2021 | $-0.51 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ADMA | $11.07 | +3.7% | 2.87M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |